ロード中...
Anti-angiogenic Agents in Combination With Immune Checkpoint Inhibitors: A Promising Strategy for Cancer Treatment
Advances in cancer immunity have promoted a major breakthrough in the field of cancer therapy. This is mainly associated with the successful development of immune checkpoint inhibitors (ICIs) for multiple types of human tumors. Blockade with different ICIs, including programmed cell death 1 (PD-1),...
保存先:
| 出版年: | Front Immunol |
|---|---|
| 主要な著者: | , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Frontiers Media S.A.
2020
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7477085/ https://ncbi.nlm.nih.gov/pubmed/32983126 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fimmu.2020.01956 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|